Article Information
History
- January 25, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Kai Wu1,
- Anne P. Werner2,
- Juan I. Moliva2,
- Matthew Koch1,
- Angela Choi1,
- Guillaume B. E. Stewart-Jones1,
- Hamilton Bennett1,
- Seyhan Boyoglu-Barnum2,
- Wei Shi2,
- Barney S. Graham2,
- Andrea Carfi1,
- Kizzmekia S. Corbett2,
- Robert A. Seder2 and
- Darin K. Edwards1,*
- 1Moderna Inc., Cambridge, MA, USA
- 2National Institutes of Health, National Institute of Allergy and Infectious Diseases, Vaccine Research Center, Bethesda, MD, USA
- ↵* Corresponding author; email: darin.edwards{at}modernatx.com
Posted January 25, 2021.
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants
